Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

James A. McCubrey(East Carolina University), Linda S. Steelman(East Carolina University), William H. Chappell(East Carolina University), Stephen L. Abrams(East Carolina University), Ellis W.T. Wong(East Carolina University), Fumin Chang(East Carolina University), Brian D. Lehmann(East Carolina University), David M. Terrian(East Carolina University), Michèle Milella, Agostino Tafuri(Sapienza University of Rome), Franca Stivala(University of Catania), Massimo Libra(University of Catania), Jörg Bäsecke(University of Göttingen), Camilla Evangelisti(University of Bologna), Alberto M. Martelli(University of Bologna), Richard A. Franklin(East Carolina University)
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
October 10, 2006
10.1016/j.bbamcr.2006.10.001
Cited by 2,284Open Access
Full Text

Abstract

Related Papers

Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
M Kuro-o, Y Matsumura, H Aizawa et al.|PubMed|1997|66.6k
Activation of Mitogen-activated Protein Kinase by H2O2
Kathryn Z. Guyton, Liu Y, Myriam Gorospe et al.|Journal of Biological Chemistry|1996|1.2k
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Linda S. Steelman, Steven C. Pohnert, J G Shelton et al.|Leukemia|2004|686
Identification of the sites in MAP kinase kinase‐1 phosphorylated by p74raf‐1.
Dario R. Alessi, Yuji Saito, David G. Campbell et al.|The EMBO Journal|1994|551
Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents.
Axel Knebel, Hans J. Rahmsdorf, A. Ullrich et al.|The EMBO Journal|1996|515